These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11718183)

  • 21. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
    Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
    Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures.
    Ziere G; Dieleman JP; van der Cammen TJ; Hofman A; Pols HA; Stricker BH
    J Clin Psychopharmacol; 2008 Aug; 28(4):411-7. PubMed ID: 18626268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report.
    Ozalp E; Soygur H; Cankurtaran ES; Turhan L; Cekic T; Akarsu ES; Palaoglu O; Ayhan IH
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1337-9. PubMed ID: 16600451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current approaches to management of depression in Parkinson's Disease.
    Vajda FJ; Solinas C
    J Clin Neurosci; 2005 Sep; 12(7):739-43. PubMed ID: 16026985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitor-induced akathisia.
    Koliscak LP; Makela EH
    J Am Pharm Assoc (2003); 2009; 49(2):e28-36; quiz e37-8. PubMed ID: 19289334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
    Geddes JR; Freemantle N; Mason J; Eccles MP; Boynton J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001851. PubMed ID: 17636689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants.
    Ginzburg R; Rosero E
    Ann Pharmacother; 2009 Jan; 43(1):98-103. PubMed ID: 19116378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.
    Renoux C; Vahey S; Dell'Aniello S; Boivin JF
    JAMA Neurol; 2017 Feb; 74(2):173-180. PubMed ID: 27918771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
    Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
    Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    Sussman N; Ginsberg DL; Bikoff J
    J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective Serotonin Reuptake Inhibitor Use and Risk of Arrhythmia: A Nationwide, Population-Based Cohort Study.
    Lin YT; Lu TS; Hansen RA; Wang CC
    Clin Ther; 2019 Jun; 41(6):1128-1138.e8. PubMed ID: 31178037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
    Näslund J; Hieronymus F; Emilsson JF; Lisinski A; Nilsson S; Eriksson E
    Acta Psychiatr Scand; 2017 Oct; 136(4):343-351. PubMed ID: 28859218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective study of selegiline-antidepressant drug interactions and a review of the literature.
    Ritter JL; Alexander B
    Ann Clin Psychiatry; 1997 Mar; 9(1):7-13. PubMed ID: 9167831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients.
    Kostev K; Rex J; Eith T; Heilmaier C
    Ger Med Sci; 2014; 12():Doc15. PubMed ID: 25332703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An alert to extrapyramidal side-effects from SSRIs.
    Hoaken PC
    Can J Psychiatry; 1995 Feb; 40(1):51. PubMed ID: 7874680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.